Premium
Mesa Laboratories Inc (MLAB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Mr. Brian David ArchboldSVP of Continuous Improvement | -1,15k | 116,56k | Vente | 101,27 | 3,71k | -23,68% |
| 2026-06-16 | Ms. Lyndsey CrennenInitié | -118,00 | 11,95k | Vente | 101,27 | 1,47k | -7,42% |
| 2026-06-16 | Mr. John V. SakysVP, CFO & CAO | -1,22k | 123,85k | Vente | 101,27 | 16,59k | -6,87% |
| 2026-06-15 | Mr. Brian David ArchboldSVP of Continuous Improvement | 2,45k | 255,41k | Derivative Exercise and Retained Stock | 104,08 | 4,86k | 101,95% |
| 2026-06-15 | Mr. Brian David ArchboldSVP of Continuous Improvement | -1,78k | 0,00 | Other Derivative Disposition | 226,72 | 11,85k | -13,06% |
| 2026-06-15 | Mr. John V. SakysVP, CFO & CAO | 2,72k | 282,79k | Derivative Exercise and Retained Stock | 104,08 | 17,81k | 18,00% |
| 2026-06-15 | Mr. John V. SakysVP, CFO & CAO | -3,95k | 0,00 | Other Derivative Disposition | 226,72 | 15,76k | -20,05% |
| 2026-03-10 | Mr. Shiraz S. LadiwalaLead Independent Director | 3,50k | 252,81k | Achat | 72,23 | 8,52k | 69,68% |
| 2026-03-10 | Mr. Mark Christopher CaponeIndependent Director | 1,30k | 99,33k | Achat | 76,35 | 3,43k | 61,14% |
| 2026-03-10 | Mr. R. Tony TripenyIndependent Director | 1,32k | 99,94k | Achat | 76,00 | 5,40k | 32,21% |
| 2025-12-02 | Dr. John J. SullivanChairman of the Board | -2,00k | 0,00 | Other Disposition | - | 70,06k | -2,78% |
| 2025-10-27 | Mr. Gary M. OwensInitié | 11,56k | 0,00 | Derivative Exercise and Retained Stock | - | 64,14k | 21,98% |
| 2025-08-15 | Mr. Shiraz S. LadiwalaLead Independent Director | 1,95k | 0,00 | Derivative Exercise and Retained Stock | - | 5,02k | 63,40% |
| 2025-08-15 | Dr. John J. SullivanChairman of the Board | 1,40k | 0,00 | Derivative Exercise and Retained Stock | - | 72,06k | 1,99% |
| 2025-08-15 | Ms. Shannon M. HallIndependent Director | 1,40k | 0,00 | Derivative Exercise and Retained Stock | - | 4,19k | 50,41% |
| 2025-08-15 | Mr. R. Tony TripenyIndependent Director | 1,40k | 0,00 | Derivative Exercise and Retained Stock | - | 4,08k | 52,41% |
| 2025-08-15 | Mr. Mark Christopher CaponeIndependent Director | 1,40k | 0,00 | Derivative Exercise and Retained Stock | - | 2,13k | 193,92% |
| 2025-08-15 | Ms. Jennifer Sadie AlltoftIndependent Director | 1,40k | 0,00 | Derivative Exercise and Retained Stock | - | 4,88k | 40,41% |
| 2025-06-21 | Mr. John V. SakysVP, CFO & CAO | 582,00 | 55,77k | Derivative Exercise and Retained Stock | 95,82 | 15,14k | 4,00% |
| 2025-06-21 | Mr. John V. SakysVP, CFO & CAO | -454,00 | 0,00 | Derivative Exercise and Sale | 95,82 | 15,14k | - |
| 2025-06-21 | Mr. Brian David ArchboldSVP of Continuous Improvement | 459,00 | 43,98k | Derivative Exercise and Retained Stock | 95,82 | 2,41k | 23,56% |
| 2025-06-21 | Mr. Brian David ArchboldSVP of Continuous Improvement | -385,00 | 0,00 | Derivative Exercise and Sale | 95,82 | 2,41k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
